According to Zhitong Finance App News, Buchang Pharmaceutical (603858.SH) announced that the company expects to achieve a net profit loss of about 428 million yuan to 808 million yuan in 2024 belonging to the owner of the parent company. Compared with the same period last year, there will be a loss.

Zhitongcaijing · 01/20 11:41
According to Zhitong Finance App News, Buchang Pharmaceutical (603858.SH) announced that the company expects to achieve a net profit loss of about 428 million yuan to 808 million yuan in 2024 belonging to the owner of the parent company. Compared with the same period last year, there will be a loss.